Business

AMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING

Imaging Biometrics Limited has issued an amendment to its Notice of Annual General Meeting, correcting an error regarding a proposed share sub-division. The ordinary shares of £0.01 will be sub-divided into one ordinary share of £0.005, not £0.0005 as previously stated. The total number of ordinary shares in issue will remain 246,709,789, assuming the resolution passes at the AGM scheduled for June 3, 2026. All other resolutions remain unchanged. Disclaimer*

articleImaging Biometrics LimitedMay 13, 20265/company/imaging-biometrics-limited/news/amendement-to-notice-of-annual-general-meeting
AMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING

About this update from Imaging Biometrics Limited

[{"type":"text","content":"\n\n \nImaging Biometrics Limited\n(\"IBAI\" or the \"Company\")\nAMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING\n \nThe Company notes an error to RNS 12 May 2026 (RNS Number: 0280E), that incorrectly stated that the ordinary shares of £0.01 will be sub-divided into one ordinary share of £0.0005. The ordinary shares of £0.01 will in fact be sub-divided into one ordinary share of £0.005.\nThe corrected Notice of AGM will shortly be available at  https://imagingbiometrics.com/. All other resolutions have not been amended.\nThe corrected announcement reads:\nImaging Biometrics Limited, the Main Market listed healthcare technology group, is pleased to announce that its Annual General Meeting (\"AGM\") will be held at IFC5, St Helier, Jersey, JE1 1ST on 3 June 2026 at 10:00 am.  \n \nThe Notice of AGM includes, inter alia, details of a proposed share sub-division whereby each current ordinary share of £0.01 will be sub-divided into one ordinary share of £0.005. The number of ordinary shares in issue will not change and will remain at 246,709,789 ordinary shares of £0.005, assuming that the sub-division resolution is passed at the AGM.\n \nA form of proxy will accompany the Notice of AGM and the Noice of AGM will shortly be available at https://imagingbiometrics.com/\n \nThe Directors of the Company accept responsibility for the contents of this announcement.\n For further information, please contact:\n \n\n\n\n\nImaging Biometrics Limited\nTrevor Brown / Brett Skelly / Michael Schmainda / John Richardson\nTel: 020 7469 0930\n\n\n\n\nAlbR Capital Limited (Corporate Broker)\nLucy Williams / Duncan Vasey\nTel: 020 7220 9797\n\n\n\n\n \n \nNotes to Editors\nAbout Imaging Biometrics Limited\nImaging Biometrics Limited is an LSE-listed healthcare technology group focused on quantitative neuroimaging software and organ-on-a-chip technology. Its principal subsidiary, Imaging Biometrics LLC, is a world leader in advanced MRI analysis software used in the assessment of brain tumours, with products distributed globally including through a commercial agreement with GE HealthCare. Kirkstall Limited, acquired by IBAI in October 2025, develops the Quasi Vivo® organ-on-a-chip platform for use in pharmaceutical research, toxicology testing and disease modelling.\nAbout Kirksta...

More updates from Imaging Biometrics Limited